Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""liver disease"" wg kryterium: Temat


Tytuł:
Severity and Remission of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence.
Autorzy:
Gao J; Department of Intensive Care Unit Kailuan General Hospital Tangshan China.
Li Y; Department of Epidemiology and Health Statistics, School of Public Health Capital Medical University Beijing China.; Beijing Municipal Key Laboratory of Clinical Epidemiology Beijing China.
Zhang Y; Department of Neurology Beijing Tiantan Hospital Capital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing Tiantan Hospital Capital Medical University Beijing China.; Department of Clinical Epidemiology and Clinical Trial Capital Medical University Beijing China.
Zhan X; School of Public Health The University of Sydney Sydney Australia.
Tian X; Department of Epidemiology and Health Statistics, School of Public Health Capital Medical University Beijing China.; Beijing Municipal Key Laboratory of Clinical Epidemiology Beijing China.
Li J; Department of Cardiology Kailuan General Hospital Tangshan China.
Wang R; Department of Cardiology Kailuan General Hospital Tangshan China.
He Y; Department of Epidemiology and Health Statistics, School of Public Health Capital Medical University Beijing China.; Beijing Municipal Key Laboratory of Clinical Epidemiology Beijing China.
Wang A; Department of Neurology Beijing Tiantan Hospital Capital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing Tiantan Hospital Capital Medical University Beijing China.; Department of Clinical Epidemiology and Clinical Trial Capital Medical University Beijing China.
Wu S; Department of Cardiology Kailuan General Hospital Tangshan China.
Pokaż więcej
Źródło:
Journal of the American Heart Association [J Am Heart Assoc] 2024 Mar 05; Vol. 13 (5), pp. e032604. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/epidemiology
Renal Insufficiency, Chronic*/complications
Renal Insufficiency, Chronic*/diagnosis
Renal Insufficiency, Chronic*/epidemiology
Humans ; Ethanol ; Causality ; Proteinuria
Czasopismo naukowe
Tytuł:
Recent Advances in Mesenchymal Stem/Stromal Cell-Based Therapy for Alcohol-Associated Liver Disease and Non-alcoholic Fatty Liver Disease.
Autorzy:
Korkida F; Laboratory of Biology, School of Medicine, National and Kapodistrian University of Athens (NKUA), Athens, Greece.
Stamatopoulou A; Laboratory of Biology, School of Medicine, National and Kapodistrian University of Athens (NKUA), Athens, Greece.
Roubelakis MG; Laboratory of Biology, School of Medicine, National and Kapodistrian University of Athens (NKUA), Athens, Greece.; Cell and Gene Therapy Laboratory, Centre of Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece.
Pokaż więcej
Źródło:
Stem cells translational medicine [Stem Cells Transl Med] 2024 Feb 14; Vol. 13 (2), pp. 107-115.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/therapy
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/pathology
Liver Diseases, Alcoholic*/complications
Liver Diseases, Alcoholic*/pathology
Liver Diseases, Alcoholic*/therapy
Mesenchymal Stem Cells*/pathology
Humans ; Liver/pathology ; Liver Cirrhosis/pathology
Czasopismo naukowe
Tytuł:
Severity of fatty liver is highly correlated with the risk of hypertension and diabetes: a cross-sectional and longitudinal cohort study.
Autorzy:
Shih CI; Department of Medical Education and Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; School of Medicine and Doctoral Program of Clinical and Experimental Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Wu KT; Department of Preventive Medicine, and Health Management Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsieh MH; Department of Preventive Medicine, and Health Management Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou Road, Kaohsiung City, 807, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yang JF; Department of Preventive Medicine, and Health Management Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chen YY; Department of Preventive Medicine, and Health Management Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Tsai WL; School of Medicine and Doctoral Program of Clinical and Experimental Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-Sen University, Kaohsiung, Taiwan.; Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Chen WC; School of Medicine and Doctoral Program of Clinical and Experimental Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-Sen University, Kaohsiung, Taiwan.; Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Liang PC; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou Road, Kaohsiung City, 807, Taiwan.
Wei YJ; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou Road, Kaohsiung City, 807, Taiwan.
Tsai PC; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou Road, Kaohsiung City, 807, Taiwan.
Hsu PY; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou Road, Kaohsiung City, 807, Taiwan.
Hsieh MY; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou Road, Kaohsiung City, 807, Taiwan.
Lin YH; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou Road, Kaohsiung City, 807, Taiwan.
Jang TY; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou Road, Kaohsiung City, 807, Taiwan.
Wang CW; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou Road, Kaohsiung City, 807, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yeh ML; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou Road, Kaohsiung City, 807, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang CF; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou Road, Kaohsiung City, 807, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang JF; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou Road, Kaohsiung City, 807, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Dai CY; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou Road, Kaohsiung City, 807, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Ho CK; Department of Preventive Medicine, and Health Management Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang WL; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou Road, Kaohsiung City, 807, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yu ML; School of Medicine and Doctoral Program of Clinical and Experimental Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-Sen University, Kaohsiung, Taiwan. .; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou Road, Kaohsiung City, 807, Taiwan. .; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan. .
Pokaż więcej
Źródło:
Hepatology international [Hepatol Int] 2024 Feb; Vol. 18 (1), pp. 138-154. Date of Electronic Publication: 2023 Sep 25.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus*/epidemiology
Hypertension*/epidemiology
Non-alcoholic Fatty Liver Disease*/diagnostic imaging
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/complications
Adult ; Humans ; Longitudinal Studies ; Retrospective Studies ; Cross-Sectional Studies ; Risk Factors ; Cohort Studies
Czasopismo naukowe
Tytuł:
Exercise training improves serum biomarkers of liver fibroinflammation in patients with metabolic dysfunction-associated steatohepatitis.
Autorzy:
Harris SJ; College of Medicine, The Pennsylvania State University, Hershey, Pennsylvania, USA.
Smith N; Division of Gastroenterology and Hepatology, Department of Medicine, Penn State Health-Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.; Fatty Liver Program, Penn State Health-Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
Hummer B; Division of Gastroenterology and Hepatology, Department of Medicine, Penn State Health-Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.; Fatty Liver Program, Penn State Health-Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
Schreibman IR; Division of Gastroenterology and Hepatology, Department of Medicine, Penn State Health-Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.; Fatty Liver Program, Penn State Health-Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.; Liver Center, Penn State Health-Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
Faust AJ; Division of Gastroenterology and Hepatology, Department of Medicine, Penn State Health-Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.; Fatty Liver Program, Penn State Health-Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.; Liver Center, Penn State Health-Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
Geyer NR; Department of Public Health Sciences, The Pennsylvania State University-College of Medicine, Hershey, Pennsylvania, USA.
Chinchilli VM; Department of Public Health Sciences, The Pennsylvania State University-College of Medicine, Hershey, Pennsylvania, USA.
Sciamanna C; College of Medicine, The Pennsylvania State University, Hershey, Pennsylvania, USA.
Loomba R; Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Diego, San Diego, California, USA.; NAFLD Research Center, University of California San Diego, San Diego, California, USA.
Stine JG; Division of Gastroenterology and Hepatology, Department of Medicine, Penn State Health-Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.; Fatty Liver Program, Penn State Health-Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.; Liver Center, Penn State Health-Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.; Department of Public Health Sciences, The Pennsylvania State University-College of Medicine, Hershey, Pennsylvania, USA.; Cancer Institute, Penn State Health-Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2024 Feb; Vol. 44 (2), pp. 532-540. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/therapy
Non-alcoholic Fatty Liver Disease*/metabolism
Humans ; Liver/pathology ; Exercise/physiology ; Liver Cirrhosis/pathology ; Biomarkers ; Weight Loss
Czasopismo naukowe
Tytuł:
How best to combine liver transplantation and bariatric surgery?-Results from a global, web-based survey.
Autorzy:
Widmer J; Department of Surgery and Transplantation, Swiss HPB Centre, University Hospital Zurich, Zurich, Switzerland.
Eden J; Department of Surgery and Transplantation, Swiss HPB Centre, University Hospital Zurich, Zurich, Switzerland.
Abbassi F; Department of Surgery and Transplantation, Swiss HPB Centre, University Hospital Zurich, Zurich, Switzerland.
Angelico R; HPB and Transplant Unit, Department of Surgical Sciences, University of Rome Tor Vergata, Rome, Italy.
Rössler F; Department of Surgery and Transplantation, Swiss HPB Centre, University Hospital Zurich, Zurich, Switzerland.
Müllhaupt B; Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
Dutkowski P; Department of Surgery and Transplantation, Swiss HPB Centre, University Hospital Zurich, Zurich, Switzerland.
Bueter M; Department of Surgery and Transplantation, Swiss HPB Centre, University Hospital Zurich, Zurich, Switzerland.; Department of Surgery, Spital Männedorf, Männedorf, Switzerland.
Schlegel A; Department of Surgery and Transplantation, Swiss HPB Centre, University Hospital Zurich, Zurich, Switzerland.; Transplantation Center, Digestive Disease and Surgery Institute and Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Centre of Preclinical Research, Milan, Italy.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2024 Feb; Vol. 44 (2), pp. 566-576. Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/surgery
Non-alcoholic Fatty Liver Disease*/etiology
Liver Transplantation*/adverse effects
Bariatric Surgery*/adverse effects
Bariatric Surgery*/methods
Obesity, Morbid*
Gastric Bypass*/adverse effects
Gastric Bypass*/methods
Humans ; Male ; Obesity/surgery ; Internet ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Gastrointestinal cancers in lean individuals with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Autorzy:
Souza M; Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Diaz I; Department of Internal Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York, USA.
Barchetta I; Department of Experimental Medicine, Sapienza University, Rome, Italy.
Mantovani A; Section of Endocrinology, Diabetes and Metabolism, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2024 Jan; Vol. 44 (1), pp. 6-14. Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/epidemiology
Gastrointestinal Neoplasms*/epidemiology
Gastrointestinal Neoplasms*/complications
Colorectal Neoplasms*/complications
Humans ; Risk Factors
Czasopismo naukowe
Tytuł:
The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review.
Autorzy:
Zachou M; Gastroenterology Department, 'Sismanoglio' General Hospital, 151 26, Athens, Greece.
Flevari P; Expertise Center in Rare Haematological Diseases-Haemoglobinopathies, 'Laiko' General Hospital, 115 27, Athens, Greece.
Nasiri-Ansari N; Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 115 27, Athens, Greece.
Varytimiadis C; Gastroenterology Department, 'Evangelismos' General Hospital, 106 76, Athens, Greece.
Kalaitzakis E; Department of Gastroenterology, University Hospital of Heraklion, University of Crete, 715 00, Heraklion, Greece.
Kassi E; Unit of Molecular Endocrinology, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 115 27, Athens, Greece.; Endocrine Unit, 1st Department of Propaedeutic Internal Medicine, 'Laiko' Hospital, National and Kapodistrian University of Athens, 115 27, Athens, Greece.
Androutsakos T; Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, Mikras Asias 75, 115 27, Athens, Greece. .
Pokaż więcej
Źródło:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Jan; Vol. 80 (1), pp. 127-150. Date of Electronic Publication: 2023 Nov 08.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/drug therapy
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/pathology
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/complications
Insulin Resistance*/physiology
Metformin*/pharmacology
Humans ; Pioglitazone/therapeutic use ; Hypoglycemic Agents/adverse effects ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/complications
Czasopismo naukowe
Tytuł:
Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults.
Autorzy:
Zeng F; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, No.601 Huangpu Road West, Guangzhou, 510632, China. .; Department of Epidemiology, Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-Sen University, Guangzhou, 510275, China. .
Su X; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, No.601 Huangpu Road West, Guangzhou, 510632, China.
Liang X; Zhejiang Key Laboratory of Multi-Omics in Infection and Immunity, School of Medicine and School of Life Sciences, Westlake University, Hangzhou, 310030, China.
Liao M; Institute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany.
Zhong H; Department of Epidemiology, Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-Sen University, Guangzhou, 510275, China.
Xu J; Department of Epidemiology, Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-Sen University, Guangzhou, 510275, China.
Gou W; Zhejiang Key Laboratory of Multi-Omics in Infection and Immunity, School of Medicine and School of Life Sciences, Westlake University, Hangzhou, 310030, China.
Zhang X; Big Data Decision Institute, Jinan University, No.601 Huangpu Road West, Guangzhou, 510632, China.
Shen L; Zhejiang Key Laboratory of Multi-Omics in Infection and Immunity, School of Medicine and School of Life Sciences, Westlake University, Hangzhou, 310030, China.
Zheng JS; Zhejiang Key Laboratory of Multi-Omics in Infection and Immunity, School of Medicine and School of Life Sciences, Westlake University, Hangzhou, 310030, China. .
Chen YM; Department of Epidemiology, Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-Sen University, Guangzhou, 510275, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Mar 07; Vol. 22 (1), pp. 104. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/metabolism
Gastrointestinal Microbiome*
Microbiota*
Middle Aged ; Humans ; Animals ; Mice ; Aged ; Liver/metabolism ; Independent Living
Czasopismo naukowe
Tytuł:
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.
Autorzy:
Cao L; The Third Central Hospital of Tianjin, Tianjin, China.
An Y; Department of Endocrinology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Liu H; Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, No. 36, San Hao Street, Shenyang, Liaoning, 110004, China.; Liaoning Key Laboratory of Precision Medical Research On Major Chronic Disease, Liaoning Province, Shenyang, China.
Jiang J; Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, No. 36, San Hao Street, Shenyang, Liaoning, 110004, China.; Liaoning Key Laboratory of Precision Medical Research On Major Chronic Disease, Liaoning Province, Shenyang, China.
Liu W; Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, No. 36, San Hao Street, Shenyang, Liaoning, 110004, China.; Liaoning Key Laboratory of Precision Medical Research On Major Chronic Disease, Liaoning Province, Shenyang, China.
Zhou Y; Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, No. 36, San Hao Street, Shenyang, Liaoning, 110004, China.; Liaoning Key Laboratory of Precision Medical Research On Major Chronic Disease, Liaoning Province, Shenyang, China.
Shi M; Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, No. 36, San Hao Street, Shenyang, Liaoning, 110004, China.; Liaoning Key Laboratory of Precision Medical Research On Major Chronic Disease, Liaoning Province, Shenyang, China.
Dai W; Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, No. 36, San Hao Street, Shenyang, Liaoning, 110004, China.; Liaoning Key Laboratory of Precision Medical Research On Major Chronic Disease, Liaoning Province, Shenyang, China.
Lv Y; Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Zhao Y; Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, No. 36, San Hao Street, Shenyang, Liaoning, 110004, China.; Liaoning Key Laboratory of Precision Medical Research On Major Chronic Disease, Liaoning Province, Shenyang, China.
Lu Y; School of Nursing, Peking University, 38 Xueyuan Rd, Haidian District, Beijing, 100191, China. .
Chen L; Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. .
Xia Y; Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, No. 36, San Hao Street, Shenyang, Liaoning, 110004, China. .; Liaoning Key Laboratory of Precision Medical Research On Major Chronic Disease, Liaoning Province, Shenyang, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Mar 06; Vol. 22 (1), pp. 101. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/epidemiology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/epidemiology
Humans ; Risk Factors ; Databases, Factual ; Patients
Czasopismo naukowe
Tytuł:
Activation of AMPK pathway by low‑dose donafenib and atorvastatin combination improves high‑fat diet‑induced metabolic dysfunction‑associated steatotic liver disease.
Autorzy:
Bai Y; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.
Chen K; Department of Gastroenterology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, P.R. China.
Liu J; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.
Wang Y; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.
Wang C; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.
Ju S; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.
Zhou C; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.
Yao W; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.
Xiong B; Department of Interventional Radiology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, P.R. China.
Zheng C; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.
Pokaż więcej
Źródło:
Molecular medicine reports [Mol Med Rep] 2024 Mar; Vol. 29 (3). Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/etiology
Non-alcoholic Fatty Liver Disease*/complications
Metabolic Diseases*/complications
Pyridines*
Rats ; Animals ; Humans ; AMP-Activated Protein Kinases/metabolism ; Atorvastatin/pharmacology ; Atorvastatin/therapeutic use ; Reactive Oxygen Species/metabolism ; Diet, High-Fat/adverse effects ; Liver/metabolism ; Lipid Metabolism ; Hep G2 Cells
Czasopismo naukowe
Tytuł:
Artificial Intelligence in Liver Diseases: Recent Advances.
Autorzy:
Lu F; College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China.; Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China.
Meng Y; Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China.; Postgraduate College, Dalian Medical University, Dalian, China.
Song X; Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China.; Postgraduate College, Dalian Medical University, Dalian, China.
Li X; Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China.; Postgraduate College, China Medical University, Shenyang, China.
Liu Z; Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China.; Postgraduate College, China Medical University, Shenyang, China.
Gu C; Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China.; Postgraduate College, China Medical University, Shenyang, China.
Zheng X; Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China.; Postgraduate College, China Medical University, Shenyang, China.
Jing Y; Neusoft Research of Intelligent Healthcare Technology, Co. Ltd., Shenyang, China.
Cai W; Neusoft Research of Intelligent Healthcare Technology, Co. Ltd., Shenyang, China.
Pinyopornpanish K; Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Mancuso A; Medicina Interna 1, Azienda di Rilievo Nazionale Ad Alta Specializzazione Civico-Di Cristina-Benfratelli, Palermo, Italy. .
Romeiro FG; Internal Medicine Department, Botucatu Medical School, São Paulo, Brazil. .
Méndez-Sánchez N; Liver Research Unit, Medica Sur Clinic and Foundation, National Autonomous University of Mexico, Mexico City, Mexico. .
Qi X; College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China. .; Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China. .; Postgraduate College, Dalian Medical University, Dalian, China. .; Postgraduate College, China Medical University, Shenyang, China. .
Pokaż więcej
Źródło:
Advances in therapy [Adv Ther] 2024 Mar; Vol. 41 (3), pp. 967-990. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Hepatocellular*
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/therapy
Liver Neoplasms*/diagnosis
Humans ; Artificial Intelligence ; Liver Cirrhosis/complications ; Liver Cirrhosis/diagnosis
Czasopismo naukowe
Tytuł:
Hepatic-Accumulated Obeticholic Acid and Atorvastatin Self-Assembled Nanocrystals Potentiate Ameliorative Effects in Treatment of Metabolic-Associated Fatty Liver Disease.
Autorzy:
Lu H; School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou, Guangdong, 511442, China.; National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, Guangdong, 510006, China.
Ban Z; National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, Guangdong, 510006, China.; School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, China.
Xiao K; National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, Guangdong, 510006, China.; School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, China.
Sun M; School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou, Guangdong, 511442, China.; National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, Guangdong, 510006, China.
Liu Y; College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China.
Chen F; National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, Guangdong, 510006, China.
Shi T; School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou, Guangdong, 511442, China.; National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, Guangdong, 510006, China.
Chen L; College of Medicine, Jilin University, Changchun, 130021, China.
Shao D; School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou, Guangdong, 511442, China.; National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, Guangdong, 510006, China.; School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, China.
Zhang M; College of Medicine, Jilin University, Changchun, 130021, China.
Li W; College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China.
Pokaż więcej
Źródło:
Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Mar; Vol. 11 (10), pp. e2308866. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/drug therapy
Non-alcoholic Fatty Liver Disease*/metabolism
Chenodeoxycholic Acid/*analogs & derivatives
Animals ; Mice ; Atorvastatin/therapeutic use ; Inflammation/drug therapy
Czasopismo naukowe
Tytuł:
Platelet-associated biomarkers in nonalcoholic steatohepatitis: Insights from a female cohort with obesity.
Autorzy:
Duran-Bertran J; Grup de Recerca GEMMAIR (AGAUR) - Medicina Aplicada (URV), Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Servei Medicina Interna, Departament de Medicina i Cirurgia, Hospital Universitari de Tarragona Joan XXIII, URV, Tarragona, Spain.
Rusu EC; Grup de Recerca GEMMAIR (AGAUR) - Medicina Aplicada (URV), Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.
Barrientos-Riosalido A; Grup de Recerca GEMMAIR (AGAUR) - Medicina Aplicada (URV), Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.
Bertran L; Grup de Recerca GEMMAIR (AGAUR) - Medicina Aplicada (URV), Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.
Mahmoudian R; Grup de Recerca GEMMAIR (AGAUR) - Medicina Aplicada (URV), Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.
Aguilar C; Grup de Recerca GEMMAIR (AGAUR) - Medicina Aplicada (URV), Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.
Riesco D; Grup de Recerca GEMMAIR (AGAUR) - Medicina Aplicada (URV), Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Servei Medicina Interna, Departament de Medicina i Cirurgia, Hospital Universitari de Tarragona Joan XXIII, URV, Tarragona, Spain.
Martínez S; Grup de Recerca GEMMAIR (AGAUR) - Medicina Aplicada (URV), Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Servei Anatomia Patològica, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.
Ugarte Chicote J; Grup de Recerca GEMMAIR (AGAUR) - Medicina Aplicada (URV), Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Servei Anatomia Patològica, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.
Sabench F; Grup de Recerca GEMMAIR (AGAUR) - Medicina Aplicada (URV), Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Servei de Cirurgia, Departament de Medicina i Cirurgia, Hospital Sant Joan de Reus, URV, IISPV, Reus, Spain.
Richart C; Grup de Recerca GEMMAIR (AGAUR) - Medicina Aplicada (URV), Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.
Auguet T; Grup de Recerca GEMMAIR (AGAUR) - Medicina Aplicada (URV), Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Servei Medicina Interna, Departament de Medicina i Cirurgia, Hospital Universitari de Tarragona Joan XXIII, URV, Tarragona, Spain.
Pokaż więcej
Źródło:
European journal of clinical investigation [Eur J Clin Invest] 2024 Mar; Vol. 54 (3), pp. e14123. Date of Electronic Publication: 2023 Nov 06.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/complications
Obesity, Morbid*
Metabolic Diseases*/complications
Humans ; Female ; Mean Platelet Volume ; Biomarkers ; Inflammation/complications ; Polyesters ; Blood Platelets
Czasopismo naukowe
Tytuł:
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease is associated with heterogeneous pattern of fat infiltration in skeletal muscles.
Autorzy:
Nachit M; Laboratory of Hepato-Gastroenterology, Institut de Recherche Expérimentale et Clinique, UCLouvain, Brussels, Belgium. .; Department of Imaging and Pathology, KU Leuven, Louvain, Belgium. .
Dioguardi Burgio M; Laboratory of Imaging Biomarkers, Center of Research On Inflammation, Université Paris Cité, Inserm, Paris, France.; Department of Radiology, Beaujon University Hospital Paris Nord, AP-HP, Clichy, France.
Abyzov A; Laboratory of Imaging Biomarkers, Center of Research On Inflammation, Université Paris Cité, Inserm, Paris, France.
Garteiser P; Laboratory of Imaging Biomarkers, Center of Research On Inflammation, Université Paris Cité, Inserm, Paris, France.
Paradis V; Team 'From Inflammation to Cancer in Digestive Disease', Center of Research on Inflammation, Université Paris Cité, Inserm, Paris, France.; Department of Pathology, Beaujon University Hospital Paris Nord, AP-HP, Clichy, France.
Vilgrain V; Laboratory of Imaging Biomarkers, Center of Research On Inflammation, Université Paris Cité, Inserm, Paris, France.; Department of Radiology, Beaujon University Hospital Paris Nord, AP-HP, Clichy, France.
Leclercq I; Laboratory of Hepato-Gastroenterology, Institut de Recherche Expérimentale et Clinique, UCLouvain, Brussels, Belgium.
Van Beers BE; Laboratory of Imaging Biomarkers, Center of Research On Inflammation, Université Paris Cité, Inserm, Paris, France.; Department of Radiology, Beaujon University Hospital Paris Nord, AP-HP, Clichy, France.
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2024 Mar; Vol. 34 (3), pp. 1461-1470. Date of Electronic Publication: 2023 Sep 02.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/diagnostic imaging
Non-alcoholic Fatty Liver Disease*/pathology
Carcinoma, Hepatocellular*/complications
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/complications
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/pathology
Humans ; Cross-Sectional Studies ; Liver/pathology ; Liver Cirrhosis/pathology ; Muscle, Skeletal/diagnostic imaging ; Muscle, Skeletal/pathology
Czasopismo naukowe
Tytuł:
Comparison between the effect of Empagliflozin and Pioglitazone added to metformin in patients with type 2 diabetes and nonalcoholic fatty liver disease.
Autorzy:
Hooshmand Gharabagh L; Department of Internal Medicine, School of Medicine, Urmia University of Medical Sciences, Imam Khomeini Hospital, Urmia, Iran. Electronic address: .
Shargh A; Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran.
Mohammad Hosseini Azar MR; Department of Internal Medicine, School of Medicine, Urmia University of Medical Sciences, Imam Khomeini Hospital, Urmia, Iran.
Esmaeili A; Department of Clinical Pharmacy, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran; Experimentaland Applied Pharmaceutical Sciences Research Center, Urmia University of Medical Sciences, Urmia, Iran. Electronic address: .
Pokaż więcej
Źródło:
Clinics and research in hepatology and gastroenterology [Clin Res Hepatol Gastroenterol] 2024 Mar; Vol. 48 (3), pp. 102279. Date of Electronic Publication: 2023 Dec 29.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Metformin*/therapeutic use
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/drug therapy
Benzhydryl Compounds*
Glucosides*
Humans ; Pioglitazone/therapeutic use ; Hypoglycemic Agents/therapeutic use ; Prospective Studies ; Lipids
Czasopismo naukowe
Tytuł:
Association of five diet scores with severe NAFLD incidence: A prospective study from UK Biobank.
Autorzy:
Petermann-Rocha F; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.; Centro de Investigación Biomédica, Facultad de Medicina, Universidad Diego Portales, Santiago, Chile.
Carrasco-Marin F; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.; Centro de Vida Saludable, Universidad de Concepción, Concepción, Chile.
Boonpor J; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.; Faculty of Public Health, Kasetsart University, Chalermphrakiat Sakon Nakhon Province Campus, Kasetsart University, Sakon Nakhon, Thailand.
Parra-Soto S; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.; Department of Nutrition and Public Health, Universidad del Bío-Bío, Chillán, Chile.
Shannon O; Human Nutrition & Exercise Research Centre, Centre for Healthier Lives, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Malcomson F; Human Nutrition & Exercise Research Centre, Centre for Healthier Lives, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Phillips N; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
Jain M; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
Deo S; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.; Surgical Services, Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, USA.; Case School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Livingstone KM; Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, Victoria, Australia.
Dingle SE; Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, Victoria, Australia.
Mathers JC; Human Nutrition & Exercise Research Centre, Centre for Healthier Lives, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Forrest E; Department of Gastroenterology, Glasgow Royal Infirmary, University of Glasgow, Glasgow, UK.
Ho FK; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Pell JP; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Celis-Morales C; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.; Human Performance Laboratory, Education, Physical Activity and Health Research Unit, Universidad Católica del Maule, Talca, Chile.
Pokaż więcej
Źródło:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Mar; Vol. 26 (3), pp. 860-870. Date of Electronic Publication: 2023 Nov 23.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/etiology
Diet, Mediterranean*
Humans ; Prospective Studies ; Risk Factors ; Biological Specimen Banks ; UK Biobank ; Diet/adverse effects
Czasopismo naukowe
Tytuł:
Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study.
Autorzy:
Krishnan A; Department of Supportive Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA. .; Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .; Department of Medicine, Section of Gastroenterology and Hepatology, West Virginia University School of Medicine, Morgantown, WV, USA. .
Schneider CV; Department of Medicine III, Gastroenterology, Metabolic Diseases, and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany.
Hadi Y; Department of Medicine, Section of Gastroenterology and Hepatology, West Virginia University School of Medicine, Morgantown, WV, USA.
Mukherjee D; Department of Medicine, Apex Institute of Medical Science, Kolkata, West Bengal, India.
AlShehri B; Diabetes and Endocrinology, Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
Alqahtani SA; Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Liver Transplant Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Pokaż więcej
Źródło:
Diabetologia [Diabetologia] 2024 Mar; Vol. 67 (3), pp. 483-493. Date of Electronic Publication: 2023 Dec 20.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/epidemiology
Non-alcoholic Fatty Liver Disease*/drug therapy
Non-alcoholic Fatty Liver Disease*/complications
Cardiovascular Diseases*
Heart Failure*/complications
Humans ; Young Adult ; Adult ; Hypoglycemic Agents/therapeutic use ; Glucagon-Like Peptide-1 Receptor Agonists ; Glucose ; Retrospective Studies ; Cohort Studies ; Treatment Outcome ; Glucagon-Like Peptide-1 Receptor/agonists
Czasopismo naukowe
Tytuł:
Non-linear associations of circulating total bilirubin concentration with the risk of nonalcoholic fatty liver disease and all-cause mortality.
Autorzy:
Han H; Department of Health, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Yu Q; Department of Internal Medicine, The People's Hospital of Huaiyin, Jinan 250021, China.
Qin N; Department of Nutrition, Qilu Hospital of Shandong University, Jinan, China.
Song B; Department of Out-patient, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Meng Y; Department of Nutrition, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Feng Z; Department of Nutrition, Qilu Hospital of Shandong University, Jinan, China.
Li Z; Department of Nutrition, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Chen L; Department of Health, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; Department of Nutrition, Qilu Hospital of Shandong University, Jinan, China. Electronic address: .
Pokaż więcej
Źródło:
Annals of hepatology [Ann Hepatol] 2024 Mar-Apr; Vol. 29 (2), pp. 101177. Date of Electronic Publication: 2023 Nov 03.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/epidemiology
Humans ; Male ; United States/epidemiology ; Female ; Nutrition Surveys ; Liver Function Tests ; Linear Models ; Bilirubin
Czasopismo naukowe
Tytuł:
Causal relationship between sleep apnea and non-alcoholic fatty liver disease: A Mendelian randomization study.
Autorzy:
Zhang Z; Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Li M; Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Ji G; Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhang L; Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Pokaż więcej
Źródło:
European journal of clinical investigation [Eur J Clin Invest] 2024 Mar; Vol. 54 (3), pp. e14116. Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/genetics
Sleep Apnea Syndromes*/epidemiology
Sleep Apnea Syndromes*/genetics
Humans ; Mendelian Randomization Analysis ; Body Mass Index ; Causality ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł:
From NAFLD to MASLD: When metabolic comorbidity matters.
Autorzy:
Hong S; Department of Gastroenterology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Sun L; Department of Pathology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Hao Y; Department of Medical Records and Statistics, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Li P; Department of Gastroenterology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Zhou Y; Department of Gastroenterology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Liang X; Department of Gastroenterology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Hu J; Department of Gastroenterology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Wei H; Department of Gastroenterology, Beijing Ditan Hospital, Capital Medical University, Beijing, China. Electronic address: .
Pokaż więcej
Źródło:
Annals of hepatology [Ann Hepatol] 2024 Mar-Apr; Vol. 29 (2), pp. 101281. Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/epidemiology
Metabolic Diseases*/diagnosis
Metabolic Diseases*/epidemiology
Humans ; Comorbidity ; Risk Factors ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies